◆ TICKERBASE · US STOCK FINANCIAL DATA LIBRARY

Home › All stocks › WST

West Pharmaceutical Services Inc (WST) Financial History

20 years of revenue, earnings, cash-flow and balance-sheet history from public filings.

HEALTHCARE · Health Care Supplies · DATA UPDATED 2026-07-16

West Pharmaceutical Services Inc (WST) operates in the Health Care Supplies industry and is headquartered in Exton, United States with about 10,800 employees. Its market capitalization is roughly $23 billion. In the fiscal year ended 2025-12-31, WST reported $3.1B in revenue and $494M in net income.

West Pharmaceutical Services, Inc. designs, manufactures, and sells containment and delivery systems for injectable drugs and healthcare products in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. It operates in two segments, Proprietary Products and Contract-Manufactured Products.

Interactive charts & full statements → Open the WST valuation workbench →

WST Revenue & Earnings History — Annual Income Statement

Income statement	TTM → 2026-03-31	2025-12-31	2024-12-31	2023-12-31	2022-12-31	2021-12-31	2020-12-31	2019-12-31	2018-12-31	2017-12-31	2016-12-31	2015-12-31	2014-12-31	2013-12-31	2012-12-31	2011-12-31	2010-12-31	2009-12-31	2008-12-31	2007-12-31	2006-12-31
Total Revenue	$3.2B	$3.1B	$2.9B	$3.0B	$2.9B	$2.8B	$2.1B	$1.8B	$1.7B	$1.6B	$1.5B	$1.4B	$1.4B	$1.4B	$1.3B	$1.2B	$1.1B	$1.1B	$1.1B	$1.0B	$913M
Gross Profit	$1.2B	$1.1B	$1.0B	$1.1B	$1.1B	$1.2B	$768M	$609M	$546M	$513M	$501M	$456M	$448M	$435M	$388M	$339M	$318M	$304M	$303M	$292M	$262M
Gross Margin %	36.2%	35.9%	34.6%	38.4%	39.5%	41.4%	35.8%	33.0%	31.8%	32.1%	33.2%	32.6%	31.5%	31.8%	30.6%	28.4%	28.7%	28.8%	28.8%	28.6%	28.7%
Operating Income (EBIT)	$666M	$617M	$595M	$711M	$764M	$759M	$419M	$297M	$255M	$229M	$197M	$129M	$182M	$162M	$136M	$116M	$106M	$106M	$125M	$113M	$106M
Operating Margin %	20.7%	20.1%	20.6%	24.1%	26.5%	26.8%	19.5%	16.1%	14.8%	14.3%	13.0%	9.2%	12.8%	11.9%	10.8%	9.7%	9.6%	10.0%	11.8%	11.1%	11.6%
Net Income	$543M	$494M	$493M	$593M	$586M	$662M	$346M	$242M	$207M	$151M	$144M	$96M	$127M	$112M	$81M	$76M	$65M	$73M	$86M	$71M	$67M
Net Margin %	16.9%	16.1%	17.0%	20.1%	20.3%	23.4%	16.1%	13.1%	12.0%	9.4%	9.5%	6.8%	8.9%	8.2%	6.4%	6.3%	5.9%	6.9%	8.2%	6.9%	7.3%
EBITDA	$844M	$724M	$744M	$844M	$808M	$880M	$519M	$403M	$353M	$326M	$288M	$218M	$272M	$248M	$200M	$183M	$161M	$166M	$186M	$158M	$150M
Earnings Per Share (EPS)	$7.47	$6.79	$6.69	$7.88	$7.73	$8.67	$4.57	$3.21	$2.74	$1.99	$1.91	$1.30	$1.75	$1.57	$1.12	$1.02	$0.89	$1.00	$1.19	$0.98	$1.00
Shares Outstanding (M)	72M	73M	74M	75M	76M	76M	76M	75M	75M	76M	75M	74M	73M	71M	72M	74M	73M	73M	72M	72M	67M

USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).

WST Quarterly Revenue & Earnings — Last 8 Quarters

Quarterly income statement	2026-03-31	2025-12-31	2025-09-30	2025-06-30	2025-03-31	2024-12-31	2024-09-30	2024-06-30
Total Revenue	$845M	$805M	$804M	$766M	$698M	$748M	$747M	$702M
Gross Profit	$296M	$304M	$294M	$273M	$233M	$274M	$265M	$231M
Gross Margin %	35.1%	37.8%	36.5%	35.7%	33.3%	36.7%	35.5%	33.0%
Operating Income (EBIT)	$177M	$157M	$174M	$158M	$128M	$171M	$168M	$131M
Operating Margin %	21.0%	19.4%	21.6%	20.6%	18.4%	22.8%	22.5%	18.6%
Net Income	$139M	$132M	$140M	$132M	$90M	$130M	$136M	$111M
Net Margin %	16.4%	16.4%	17.4%	17.2%	12.9%	17.4%	18.2%	15.8%
EBITDA	$218M	$210M	$217M	$198M	$151M	$206M	$205M	$169M
Earnings Per Share (EPS)	$1.92	$1.82	$1.93	$1.81	$1.23	$1.77	$1.85	$1.51
Shares Outstanding (M)	72M	73M	73M	73M	73M	74M	73M	74M

USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).

WST Free Cash Flow History

Cash flow	TTM → 2026-03-31	2025-12-31	2024-12-31	2023-12-31	2022-12-31	2021-12-31	2020-12-31	2019-12-31	2018-12-31	2017-12-31	2016-12-31	2015-12-31	2014-12-31	2013-12-31	2012-12-31	2011-12-31	2010-12-31	2009-12-31	2008-12-31	2007-12-31	2006-12-31
Cash from Operations (CFO)	$715M	$755M	$653M	$776M	$724M	$584M	$472M	$367M	$289M	$263M	$219M	$212M	$183M	$220M	$187M	$131M	$138M	$138M	$135M	$129M	$144M
Capital Expenditures (CapEx)	$257M	$286M	$377M	$362M	$285M	$253M	$174M	$126M	$105M	$131M	$170M	$132M	$112M	$156M	$132M	$97M	$74M	$108M	$139M	$129M	$90M
Free Cash Flow (FCF)	$458M	$469M	$276M	$414M	$439M	$331M	$298M	$241M	$184M	$132M	$49M	$81M	$71M	$65M	$55M	$34M	$64M	$30M	($4M)	$0M	$54M
FCF Margin %	14.2%	15.3%	9.6%	14.1%	15.2%	11.7%	13.9%	13.1%	10.7%	8.3%	3.3%	5.8%	5.0%	4.7%	4.4%	2.8%	5.8%	2.8%	-0.4%	-0.0%	5.9%
Dividends Paid	$62M	$61M	$59M	$57M	$54M	$51M	$48M	$45M	$42M	$39M	$36M	$32M	$29M	$27M	$25M	$23M	$22M	$20M	$19M	$18M	$16M

USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).

WST Quarterly Free Cash Flow — Last 8 Quarters

Quarterly cash flow	2026-03-31	2025-12-31	2025-09-30	2025-06-30	2025-03-31	2024-12-31	2024-09-30	2024-06-30
Cash from Operations (CFO)	$90M	$251M	$197M	$177M	$129M	$190M	$180M	$165M
Capital Expenditures (CapEx)	$43M	$76M	$63M	$75M	$71M	$105M	$81M	$100M
Free Cash Flow (FCF)	$47M	$175M	$134M	$102M	$58M	$85M	$99M	$65M
FCF Margin %	5.6%	21.7%	16.7%	13.3%	8.3%	11.4%	13.2%	9.2%
Dividends Paid	$16M	$16M	$15M	$15M	$15M	$15M	$14M	$15M

USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).

WST Balance Sheet History

Balance sheet	2026-03-31	2025-12-31	2024-12-31	2023-12-31	2022-12-31	2021-12-31	2020-12-31	2019-12-31	2018-12-31	2017-12-31	2016-12-31	2015-12-31	2014-12-31	2013-12-31	2012-12-31	2011-12-31	2010-12-31	2009-12-31	2008-12-31	2007-12-31	2006-12-31
Total Assets	$4.1B	$4.3B	$3.6B	$3.8B	$3.6B	$3.3B	$2.8B	$2.3B	$1.6B	$1.9B	$1.7B	$1.7B	$1.7B	$1.7B	$1.6B	$1.4B	$1.3B	$1.3B	$1.2B	$1.2B	$918M
Cash & Cash Equivalents	$521M	$791M	$485M	$854M	$894M	$763M	$616M	$439M	$337M	$236M	$203M	$275M	$255M	$230M	$162M	$92M	$110M	$83M	$87M	$108M	$47M
Total Liabilities	$1.1B	$1.1B	$961M	$948M	$932M	$978M	$939M	$768M	$583M	$197M	$599M	$671M	$713M	$765M	$835M	$744M	$669M	$692M	$682M	$695M	$499M
Total Debt (Short + Long-Term)	$224M	$226M	$221M	$224M	$225M	$262M	$265M	$267M	$196M	$300M	$229M	$298M	$337M	$374M	$412M	$349M	$358M	$380M	$386M	$395M	$236M
Total Shareholders' Equity	$3.0B	$3.2B	$2.7B	$2.9B	$2.7B	$2.3B	$1.9B	$1.6B	$1.4B	$1.7B	$1.1B	$1.0B	$957M	$906M	$729M	$655M	$626M	$579M	$487M	$485M	$414M

USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).

Quarterly statements, profitability ratios, price history, insider activity and institutional holders are in the interactive WST viewer.

Other Companies in Health Care Supplies

COO · Cooper Companies (The) — $14 billion
ALGN · Align Technology — $12 billion

← WSR All stocks WSTN →

About TickerBase · Data methodology & sources

TickerBase is provided for educational and informational purposes only. It does not constitute financial, investment, tax, or legal advice, or a recommendation to buy, sell, or hold any security. No price targets are published; any per-share value shown in the valuation workbench is generated entirely from reader-supplied assumptions and is not the publisher's view of fair value. Past performance does not predict future results. Figures are approximate and drawn from public filings; one-time items are noted where identified. Do your own research and consult a licensed professional before making any investment decision. The author may or may not hold positions in the securities discussed.